Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1249-1261

  Yoshikawa, Kiyotsugu ^a   Honda, Kazuo ^b   Inamoto, Takashi ^a   Shinohara, Hisashi ^a   Yamauchi, Akira ^a   Suga, Kenji ^a   Okuyama, Takazo ^a   Shimada, Toshihide ^a   Kodama, Hiroshi ^c   Noguchi, Shinzaburo ^d   Gazdar, Adi F ^e   Yamaoka, Yoshio ^a   Takahashi, Rei ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kodama Breast Clinic   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RNA SPLICING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BRCA1 PROTEIN; BREAST NEOPLASMS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; JAPAN; MAMMARY NEOPLASMS, EXPERIMENTAL; PRECIPITIN TESTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, NUDE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TISSUE FIXATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033055801     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 1994.
2. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S. A., Bristow, P., Morris, P., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
3. Katagiri, T., Emi, M., Ito, I., Kobayashi, K., Yoshimoto, M., Iwase, T., Kasumi, F., Miki, Y., Skolnick, M. H., and Nakamura, Y. Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum. Mutat., 7: 334-339, 1996.
4. Emi, M., Matsushima, M., Katagiri, T., Yoshimoto, M., Kasumi, F., Yokota, T., Nakata, T., Miki, Y., and Nakamura, Y. Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers. Jpn. J. Cancer Res., 89: 12-16, 1998.
5. Smith, S. A., Easton, D. F., Evans, D. G., and Ponder, B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2: 128-131, 1992.
6. Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995.
7. Sourvinos, G., and Spandidos, D. A. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Commun., 245: 75-80, 1998.
8. Dobrovic, A., and Simpfendorfer, D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57: 3347-3350, 1997.
9. Mancini, D. N., Rodenhiser, D. I., Ainsworth, P. J., O'Malley. F. P., Singh, S. M., Xing, W., and Archer, T. K. CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene, 16: 1161-1169, 1998.
10. Rice, J. C., Massey-Brown, K. S., and Futscher, B. W. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene, 17: 1807-1812, 1998.
11. Koonin, E. V., Altschul, S. F., and Bork, P. BRCA1 protein products. Functional motifs. Nat. Genet., 13: 266-268, 1996.
12. Chapman, M. S., and Verma, I. M. Transcriptional activation by BRCA1. Nature (Lond.), 382: 678-679, 1996.
13. Monteiro, A. N., August, A., and Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA, 93: 13595-13599, 1996.
14. Ouchi, T., Monteiro, A. N., August, A., Aaronson, S. A., and Hanafusa, H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA, 95: 2302-2306, 1998.
15. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B. L., and El-Deiry, W. S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16: 1713-1721, 1998.
16. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
17. Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D. M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90: 425-435, 1997.
18. Chen, Y., Chen, C. F., Riley, D. J., Allred, D. C., Chen, P. L., Von-Hoff, D., Osborne, C. K., and Lee, W. H. Aberrant subcellular localization of BRCA1 in breast cancer. Science (Washington DC), 270: 789-791, 1995.
19. Jensen, R. A., Thompson, M. E., Jetton, T. L., Szabo, C. I., van-der-Meer, R., Helou, B., Tronick, S. R., Page, D. L., King, M. C., and Holt, J. T. BRCA1 is secreted and exhibits properties of a granin. Nat. Genet., 12: 303-308, 1996.
20. Scully, R., Ganesan, S., Brown, M., De-Caprio, J. A., Cannistra, S. A., Feunteun, J., Schnitt, S., and Livingston, D. M. Location of BRCA1 in human breast and ovarian cancer cells. Science (Washington DC), 272: 123-126, 1996.
21. Coene, E., Van-Oostveldt, P., Willems, K., van-Emmelo, J., and De-Potter, C. R. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat. Genet., 16: 122-124, 1997.
22. Wilson, C. A., Payton, M. N., Pekar, S. K., Zhang, K., Pacifici, R. E., Gudas, J. L., Thukral, S., Calzone, F. J., Reese, D. M., and Slamon, D. I. BRCA1 protein products: antibody specificity. Nat. Genet., 13: 264-265, 1996.
23. Bernard-Gallon, D. J., Crespin, N. C., Maurizis, J. C., and Bignon, Y. J. Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA1 (C-20) and human EGF and EGF-R in MCF 10a human mammary epithelial cell line. Int. J. Cancer, 71: 123-126, 1997.
24. Wilson, C. A., Payton, M. N., Elliott, G. S., Buaas, F. W., Cajulis, E. E., Grosshans, D., Ramos, L., Reese, D. M., Slamon, D. J., and Calzone, F. J. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene, 14: 1-16, 1997.
25. Thakur, S., Zhang, H. B., Peng, Y., Le, H., Carroll, B., Ward, T., Yao, J., Farid, L. M., Couch, F. J., Wilson, R. B., and Weber, B. L. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol., 17: 444-452, 1997.
26. Tomlinson, G. E., Chen, T. T-L., Stastny, V. A., Virmani, A. K., Spillman, M. A., Tonk, V., Blum, J. L., Schneider, N. R., Wistuba, I. I., Shay, J. W., Minna, J. D., and Gazdar, A. F. Characterization of a breast cancer cell line derived from germ-line BRCA1 mutation carrier. Cancer Res., 58: 3237-3242, 1998.
27. Katagiri, T., Kasumi, F., Yoshimoto, M., Nomizu, T., Asaishi, K., Abe, R., Tsuchiya, A., Sugano, M., Takai, S., Yoneda, M., Fukutomi, T., Nanba, K., Makita, M., Okazaki, H., Hirata, K., Okazaki, M., Furutsuma, Y., Morishita, Y., Iino, Y., Karino, T., Ayabe, H., Hara, S., Kajiwara, T., Houga, S., Shimizu, T., Toi, M., Yamazaki, Y., Uchida, T., Kunitomo, K., Sonoo, H., Kurebayashi, J., Shimotsuma, K., Nakamura, Y., and Miki, Y. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J. Hum. Genet., 43: 42-48, 1998.
28. Kijima, G., Murakami, Y., Ohuchi, N., Satomi, S., and Sekiya, T. Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients. Jpn. J. Cancer Res., 89: 837-841, 1998.
29. Noguchi, S., Kasugai, T., Miki, Y., Fukutomi, T., Emi, M., and Nomizu, T. Clinicopathological analysis of BRCA1-or BRCA2-associated hereditary breast cancers in Japanese women. Cancer (Phila.), 85: 2200-2205, 1999.
30. Dousssal, V. L., Tubiana-Hulin, M., Friedman, S., Hacene, K., Spyratos, F., and Brunet, M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer (Phila.), 64: 1914-1921, 1989.
31. Fazioli, F., Minichiello, L., Matoskova, B., Wong, W. T., and Di-Fiore, P. P. Eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol. Cell. Biol., 13: 5814-5828, 1993.
32. Suzuki, M., Okuyama, T., Yoshikawa, K., Yamaoka, Y., Ariyasu, T., Fujita, M., Tankawa, H., Sugiyama, T., and Takahashi, R. Overexpression of p53, c-erbB-2 and epidermal growth factor receptor in human breast carcinomas. Pathol. Int., 46: 46-53, 1996.
33. DiGiuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, S. E., and Hruban, R. H. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol., 147: 884-888, 1995.
34. Alberts, S. R., Ingle, J. N., Roche, P. R., Cha, S. S., Wold, L. E., Farr, G., Jr., Krook, J. E., and Wieand, H. S. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials. Cancer (Phila.), 78: 764-772, 1996.
35. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G. Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet., 11: 17-26, 1995.
36. Chen, C. F., Li, S., Chen, Y., Chen, P. L., Sharp, Z. D., and Lee, W. H. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J. Biol. Chem., 271: 32863-32868, 1996.
37. Gudas, J. M., Nguyen, H., Li, T., and Cowan, K. H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55: 4561-4565, 1995.
38. Clevenger, C. V., and Shankey, T. V. Cytochemistry II: immunofluorescence measurement of intracellular antigens. In: K. D. Bauer, R. E. Duque, and T. V. Shankey (eds.), Clinical Flow Cytometry: Principles and Application, pp. 157-175. Baltimore: Williams and Wilkins, 1993.
39. Jensen, R. A., Thompson, M. E., Jetton, T. L., van-der-Meer, R., Helou, B., Arteaga, C. L., Page, D. L., Holt, J. T., Gown, A. M., Skelly, M., Ostermeyer, B., Shieltz, D., Szabo, C. I., and King, M. C. BRCA1 protein products: antibody specificity, functional motifs, and secreted tumor suppressors-reply. Nat. Genet., 13: 264-265, 1996.
40. Kainu, T., Kononen, J., Johansson, O., Olsson, H., Borg, A., and Isola, J. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res., 56; 2912-2915, 1996.
41. Ribieras, S., Magdinier, F., Leclerc, D., Lenoir, G., Frappart, L., and Dante, R. Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations. Int. J. Cancer, 73: 715-718, 1997.
42. Schorge, J. O., Muto, M. G., Welch, W. R., Bandera, C. A., Rubin, S. C., Bell, D. A., Berkowitz, R. S., and Mok, S. C. Molecular evidence for multifocal papillary serous carcinoma of the peritonium in patients with germline BRCA1 mutations. J. Natl. Cancer Inst., 90: 841-845, 1998.
43. Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M. C., Hwang, L. Y., Bowcock, A. M., and Baer, R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet., 14: 430-440, 1996.
44. Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., Minna, J., Borodovsky, A., Schultz, D. C., Wilkinson, K. D., Maul, G. G., Barlev, N., Berger, S. L., Prendergast, G. C., and Rauscher, F. R. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene, 16: 1097-1112, 1998.
45. Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., and Lynch, H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (Phila.), 77: 697-709, 1996.
46. Eisinger, F., Stoppa-Lyonnet, D., Longy, M., Kerangueven, F., Noguchi, T., Bailly, C., Vincent-Salomon, A., Jacquemier, J., Birnbaum, D., and Sobol, H. Germ line mutation at BRCA1 affects the histopathologic grade in hereditary breast cancer. Cancer Res., 56: 471-474, 1998.
47. Johannsson, O. T., Idvall, I., Anderson, C., Borg, A., Barkardottir, R. B., Egilsson, V., and Olsson, H. Tumor biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer, 33: 362-371, 1997.
48. Karp, S. E., Tonin, P. N., Begin, L. R., Martinez, J. J., Zhang, J. C., Pollak, M. N., and Foulkes, W. D. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer (Phila.), 80: 435-441, 1997.
49. Sobol, H., Lyonnet, D., Paillerets, B. B., Peyrai, J. P., Guinebretiere, J. M., Jacquemier, J., Eisinger, F., and Birnbaum, D. BRCA1-p53 relationship in hereditary breast cancer. Int. J. Oncol., 10: 349-353, 1997.
50. Hakem, R., de-la-Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., Firpo, E., Hui, C. C., Roberts, J., Rossant, J., and Mak, T. W. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85: 1009-1023, 1996.